FABP4 and Respiratory tract infection: Having established FABP4’s significance in SARS-CoV-2 adipocyte infection, we investigated its role in human bronchial epithelial (HBE) cells to understand whether it is engaged early on during respiratory tract infection (Beucher et al, 2022).